Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Deep Scientific Insights on Thiothixene's R&D Progress, Mechanism of Action, and Drug Target
Drug Insights
4 min read
Deep Scientific Insights on Thiothixene's R&D Progress, Mechanism of Action, and Drug Target
10 October 2023
This article summarized the latest R&D progress of Thiothixene, the Mechanism of Action for Thiothixene, and the drug target R&D trends for Thiothixene.
Read →
Mabwell Discloses Initial Patient Treatment in Phase Ib/II Study for Nectin-4 Focused ADC coupled with PD-1 Inhibitor
Latest Hotspot
3 min read
Mabwell Discloses Initial Patient Treatment in Phase Ib/II Study for Nectin-4 Focused ADC coupled with PD-1 Inhibitor
10 October 2023
Mabwell announced the initiation of a Phase Ib/II trial with the first patient dosage. The study uses their novel Nectin-4 ADC (9MW2821) in conjunction with a PD-1 inhibitor for advanced or metastatic urothelial carcinoma.
Read →
An In-depth Analysis of Tigecycline's R&D Progress and Mechanism of Action on Drug Target
Drug Insights
4 min read
An In-depth Analysis of Tigecycline's R&D Progress and Mechanism of Action on Drug Target
10 October 2023
This article summarized the latest R&D progress of Tigecycline, the Mechanism of Action for Tigecycline, and the drug target R&D trends for Tigecycline.
Read →
Analysis on the Clinical Research Progress of Myostatin inhibitors
Analysis on the Clinical Research Progress of Myostatin inhibitors
10 October 2023
Myostatin, a member of the transforming growth factor beta (TGF‐β) superfamily that is highly expressed in skeletalmuscle, was first described in 1997.
Read →
Trilostane: Detailed Review of its Transformative R&D Success
Drug Insights
4 min read
Trilostane: Detailed Review of its Transformative R&D Success
10 October 2023
This article summarized the latest R&D progress of Trilostane, the Mechanism of Action for Trilostane, and the drug target R&D trends for Trilostane.
Read →
ImmunoGenesis administers first patient in the Phase 1a/1b clinical study of IMGS-001 for advanced solid tumors
Latest Hotspot
3 min read
ImmunoGenesis administers first patient in the Phase 1a/1b clinical study of IMGS-001 for advanced solid tumors
10 October 2023
ImmunoGenesis announced the first patient treatment in their Phase 1a/1b trial using IMGS-001 at The University of Texas MD Anderson Cancer Center.
Read →
Pharmaceutical Insights: Plinabulin's R&D Progress and its Mechanism of Action on Drug Target
Drug Insights
4 min read
Pharmaceutical Insights: Plinabulin's R&D Progress and its Mechanism of Action on Drug Target
10 October 2023
This article summarized the latest R&D progress of Plinabulin, the Mechanism of Action for Plinabulin, and the drug target R&D trends for Plinabulin.
Read →
Analysis on the Research Progress of Chk1 inhibitor
Analysis on the Research Progress of Chk1 inhibitor
10 October 2023
Chk1, also known as checkpoint kinase 1, is a crucial protein kinase involved in the regulation of cell cycle progression and DNA damage response in the human body.
Read →
 Exploring Pindolol's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
Drug Insights
4 min read
Exploring Pindolol's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
10 October 2023
This article summarized the latest R&D progress of Pindolol, the Mechanism of Action for Pindolol, and the drug target R&D trends for Pindolol.
Read →
The FDA grants Merck accelerated consideration for their new BLA for the Activin Signaling Inhibitor, Sotatercept
Latest Hotspot
3 min read
The FDA grants Merck accelerated consideration for their new BLA for the Activin Signaling Inhibitor, Sotatercept
10 October 2023
Merck has declared that a fresh BLA for sotatercept has been approved for accelerated assessment by the U.S. FDA.
Read →
Decoding Pertuzumab: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
Drug Insights
4 min read
Decoding Pertuzumab: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
10 October 2023
This article summarized the latest R&D progress of Pertuzumab, the Mechanism of Action for Pertuzumab, and the drug target R&D trends for Pertuzumab.
Read →
Inventory of GPCR Targeted Drugs Applying for Listing (I)
Advanced Tech.
8 min read
Inventory of GPCR Targeted Drugs Applying for Listing (I)
10 October 2023
This article will review currently applied listed GPCR-targeting drugs, and the associated popular GPCR class targets and drug development opportunities worth paying attention to.
Read →